Fund Holdings — Sanofi

Total Portfolio Value:
$629.87M
Total Bought:
$137.47M
Total Sold:
$6.95M
Net Transaction:
+$130.52M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MeiraGTx Holdings plc(MGTX)12,197,73712,197,7370$164.79M$134.18M21.30%-$30.62M
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,9260$109.71M$115.89M18.40%+$6.17M
Novavax, Inc.(NVAX)6,880,4816,880,4810$64.81M$74.38M11.81%+$9.56M
Korsana Biosciences01,994,011+1,994,011$0$63.81M10.13%+$63.81M
Odyssey Therapeutics Inc.1,991,9181,990,200-1,718$37.27M$44.22M7.02%+$6.95M
AnaptysBio821,917821,9170$55.48M$41.31M6.56%-$14.17M
Agomab Therapeutics NVADS2,783,0962,783,0960$36.12M$30.89M4.90%-$5.23M
First Tracks Biotherapeutics Inc.821,917821,9170$16.54M$29.13M4.62%+$12.59M
Electra Therapeutics Inc02,461,948+2,461,948$0$27.70M4.40%+$27.70M
Attovia Therapeutics Inc01,082,855+1,082,855$0$18.56M2.95%+$18.56M
Latigo Biotherapeutics Inc0672,778+672,778$0$11.24M1.78%+$11.24M
Immuneering CorpCL A2,708,5592,708,5590$13.52M$11.09M1.76%-$2.42M
MapLight Therapeutics Inc.912,041912,0410$32.69M$9.29M1.48%-$23.39M
Scribe Therapeutics0500,000+500,000$0$9.20M1.46%+$9.20M
Sab Biotherapeutics Inc02,198,500+2,198,500$0$6.97M1.11%+$6.97M
Q32 Bio Inc.244,083244,0830$3.11M$2.02M0.32%-$1.09M
Page 1 of 1